Literature DB >> 34857662

Imaging the Inflammatory Response in Checkpoint Inhibition Myocarditis.

Christoph Rischpler1, Tienush Rassaf2, Lale Umutlu3, Ken Herrmann4, Thomas-Wilfried Schlosser3, Matthias Totzeck2.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34857662      PMCID： PMC8717203          DOI： 10.2967/jnumed.121.262301

Source DB:  PubMed          Journal:  J Nucl Med        ISSN： 0161-5505            Impact factor:   11.082


× No keyword cloud information.
  16 in total

1.  The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study.

Authors:  Maria D'Souza; Dorte Nielsen; Inge Marie Svane; Kasper Iversen; Peter Vibe Rasmussen; Christian Madelaire; Emil Fosbøl; Lars Køber; Finn Gustafsson; Charlotte Andersson; Gunnar Gislason; Christian Torp-Pedersen; Morten Schou
Journal:  Eur Heart J       Date:  2021-04-21       Impact factor: 29.983

2.  Cardiac fibroblast activation detected by positron emission tomography/computed tomography as a possible sign of cardiotoxicity.

Authors:  Matthias Totzeck; Johannes Siebermair; Tienush Rassaf; Christoph Rischpler
Journal:  Eur Heart J       Date:  2020-03-01       Impact factor: 29.983

3.  Immune checkpoint inhibitor-induced myocarditis not visible with cardiac magnetic resonance imaging but detected with PET-CT: a case report.

Authors:  Otso Arponen; Tanja Skyttä
Journal:  Acta Oncol       Date:  2020-01-10       Impact factor: 4.089

4.  Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.

Authors:  Syed S Mahmood; Michael G Fradley; Justine V Cohen; Anju Nohria; Kerry L Reynolds; Lucie M Heinzerling; Ryan J Sullivan; Rongras Damrongwatanasuk; Carol L Chen; Dipti Gupta; Michael C Kirchberger; Magid Awadalla; Malek Z O Hassan; Javid J Moslehi; Sachin P Shah; Sarju Ganatra; Paaladinesh Thavendiranathan; Donald P Lawrence; John D Groarke; Tomas G Neilan
Journal:  J Am Coll Cardiol       Date:  2018-03-19       Impact factor: 24.094

Review 5.  Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.

Authors:  Filipe Martins; Latifyan Sofiya; Gerasimos P Sykiotis; Faiza Lamine; Michel Maillard; Montserrat Fraga; Keyvan Shabafrouz; Camillo Ribi; Anne Cairoli; Yan Guex-Crosier; Thierry Kuntzer; Olivier Michielin; Solange Peters; Georges Coukos; Francois Spertini; John A Thompson; Michel Obeid
Journal:  Nat Rev Clin Oncol       Date:  2019-09       Impact factor: 66.675

6.  68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

Authors:  Clemens Kratochwil; Paul Flechsig; Thomas Lindner; Labidi Abderrahim; Annette Altmann; Walter Mier; Sebastian Adeberg; Hendrik Rathke; Manuel Röhrich; Hauke Winter; Peter K Plinkert; Frederik Marme; Matthias Lang; Hans-Ulrich Kauczor; Dirk Jäger; Jürgen Debus; Uwe Haberkorn; Frederik L Giesel
Journal:  J Nucl Med       Date:  2019-04-06       Impact factor: 10.057

7.  Initial Clinical Experience with 90Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients.

Authors:  Justin Ferdinandus; Pedro Fragoso Costa; Lukas Kessler; Manuel Weber; Nader Hirmas; Karina Kostbade; Sebastian Bauer; Martin Schuler; Marit Ahrens; Hans-Ulrich Schildhaus; Christoph Rischpler; Hong Grafe; Jens T Siveke; Ken Herrmann; Wolfgang P Fendler; Rainer Hamacher
Journal:  J Nucl Med       Date:  2021-08-12       Impact factor: 11.082

8.  Are we underestimating the potential for cardiotoxicity related to immune checkpoint inhibitors?

Authors:  Matthias Totzeck; Esther Lutgens; Tomas G Neilan
Journal:  Eur Heart J       Date:  2021-04-21       Impact factor: 35.855

Review 9.  Onco-Cardiology: Consensus Paper of the German Cardiac Society, the German Society for Pediatric Cardiology and Congenital Heart Defects and the German Society for Hematology and Medical Oncology.

Authors:  Tienush Rassaf; Matthias Totzeck; Johannes Backs; Carsten Bokemeyer; Michael Hallek; Denise Hilfiker-Kleiner; Andreas Hochhaus; Diana Lüftner; Oliver J Müller; Ulrich Neudorf; Roman Pfister; Stephan von Haehling; Lorenz H Lehmann; Johann Bauersachs
Journal:  Clin Res Cardiol       Date:  2020-05-13       Impact factor: 5.460

10.  A decade of immune-checkpoint inhibitors in cancer therapy.

Authors:  Caroline Robert
Journal:  Nat Commun       Date:  2020-07-30       Impact factor: 14.919
View more
  1 in total

Review 1.  Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology.

Authors:  David Kersting; Stephan Settelmeier; Ilektra-Antonia Mavroeidi; Ken Herrmann; Robert Seifert; Christoph Rischpler
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.